ClinicalTrials.Veeva

Menu

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

Rutgers The State University of New Jersey logo

Rutgers The State University of New Jersey

Status and phase

Enrolling
Phase 3

Conditions

Polysubstance Abuse
Opioid Use
Tobacco Use

Treatments

Other: MORE and MI and NRT
Other: Support Group and No MI and NRT
Other: MORE and No MI and NRT
Other: Support Group and MI and NRT

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06033599
Pro2022001551
R01DA057631 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.

Enrollment

420 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • English-speaking
  • Age ≥18
  • Currently on methadone; and 4) currently smoke cigarettes.

Exclusion criteria

  • Severe cognitive impairment (score >23 on Mini Mental Status Exam) or psychosis (positive SCID Psychotic Screen)
  • Suicidal risk (score ≥7 on Suicidal Behaviors Questionnaire)
  • Inability to attend or fully participate in intervention sessions or assessments
  • Previous formal mindfulness training (e.g., MBSR, MBRP) or MORE (from the R21 or R33
  • Currently taking smoking cessation pharmacotherapy or participating in smoking cessation counseling
  • Any contraindications for NRT
  • Currently or soon planning to be pregnant or breastfeeding.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

420 participants in 4 patient groups

MORE and MI
Experimental group
Treatment:
Other: MORE and MI and NRT
MORE and No MI
Experimental group
Treatment:
Other: MORE and No MI and NRT
Support Group and MI
Active Comparator group
Treatment:
Other: Support Group and MI and NRT
Support Group and No MI
Active Comparator group
Treatment:
Other: Support Group and No MI and NRT

Trial contacts and locations

2

Loading...

Central trial contact

Nina Cooperman, PsyD; Eric Garland, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems